Skip to content

Clinical trials

Phase 2 Hepatitis B, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 2 Clear all

148 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20033
20042
20052
20063
20072
20081
20093
20104
20112
20123
20131
20144
20158
20164
20174
20186
201912
202016
202113
202212
202312
202410
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75
Terminated22
Unknown status17
Recruiting16
Active, not recruiting11
Withdrawn6
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences15
Assembly Biosciences7
Ausper Biopharma Co., Ltd.6
GlaxoSmithKline5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Brii Biosciences Limited4
Bristol-Myers Squibb4
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.4
Hoffmann-La Roche4
Janssen Research & Development, LLC4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic148
Hepatitis B38
Hepatitis12
Communicable Diseases3
Infections3
Liver Diseases3
Blood-Borne Infections2
Carcinoma, Hepatocellular2
Chronic Disease2
DNA Virus Infections2

Trials

Showing 76 to 100 of 148. Each trial links to its page on Pharma Observatory.

48 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.